Healthcare
News Category
GeoVax Advances GEO-MVA Vaccine Program Toward Phase 3 Trial with Clinical Product Release
GeoVax completes release testing for GEO-MVA clinical supplies, enabling a pivotal Phase 3 immune bridging study under EMA guidance to address critica...
VolitionRx Reports Over 95% Early-Stage Cancer Detection Using Capture-Seq Technology
VolitionRx announced proof-of-concept data showing over 95% sensitivity for stage I and II cancers using its Capture-Seq liquid biopsy technology, tar...
NextPlat Corp. Schedules Full-Year 2025 Earnings Release and Conference Call for March 31
NextPlat Corp. announced its full-year 2025 earnings release and conference call on March 31, providing investors insights into its global e-commerce ...
VERAXA Biotech Showcases BiTAC Cancer Platforms Ahead of BIO International Convention
VERAXA Biotech highlights partnering opportunities for its BiTAC-ADC and BiTAC-TCE platforms, backed by new proof-of-concept data, at the upcoming BIO...
Quantum BioPharma’s Lucid-MS Targets Myelin Repair in Multiple Sclerosis, Poised for Phase 2 Trials
Quantum BioPharma is advancing Lucid-MS, a first-in-class neuroprotective therapy for multiple sclerosis that directly targets myelin repair, toward P...
Onco-Innovations Limited Announces C$5 Million Private Placement to Advance ONC010 Program
Onco-Innovations has secured C$5 million in private placement funding to advance its ONC010 cancer treatment program and SynoGraph platform.
Onco-Innovations Achieves Key Manufacturing Milestone for ONC010 Drug Candidate
Onco-Innovations completed a successful 300-gram scale-up batch of its ONC010 API with 99.3% purity, advancing its PNKP inhibitor program toward clini...
VERAXA Biotech Showcases BiTAC Cancer Platforms Ahead of BIO International Convention
VERAXA Biotech AG is highlighting its BiTAC-ADC and BiTAC-TCE platforms, which show potential for improving cancer treatment precision and reducing of...
Knight Therapeutics Repays $60 Million Credit Facility Used for Paladin Acquisition
Knight Therapeutics has fully repaid its revolving credit facility drawn to finance the Paladin acquisition, using operational cash flow, while mainta...
Quantum BioPharma’s Lucid-MS Targets Myelin Repair in Multiple Sclerosis, Advancing to Phase 2 Trials
Quantum BioPharma’s novel drug candidate Lucid-MS, which directly targets myelin repair, is preparing for phase 2 trials, offering a potential shift i...
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
The expansion of DNA Damage Response inhibitors beyond PARP inhibitors, led by companies like Onco-Innovations, AstraZeneca, and Boundless Bio, is dri...
Onco-Innovations Targets Next Wave of DNA Damage Response Cancer Therapies with PNKP Inhibitor
Onco-Innovations is advancing ONC010, a nanoparticle-encapsulated PNKP inhibitor, positioning itself as a potential leader in a novel class of cancer ...
NanoViricides Ships NV-387 Oral Gummies to DRC for Phase II MPox Trial
NanoViricides has shipped its broad-spectrum antiviral candidate NV-387 to the Democratic Republic of Congo for a Phase II clinical trial against MPox...
BioUtah Participates in National Symposium on Biotechnology's Role in National Security
BioUtah joined the Biotech Across America State Symposium in Washington, D.C. to discuss how state and local biotech ecosystems strengthen national se...
Soligenix Nears Key Clinical Milestones as Zacks Report Highlights HyBryte and Dusquetide Prospects
Soligenix is approaching critical clinical readouts in 2026, including the Phase 3 FLASH2 trial for HyBryte in CTCL and progress with dusquetide for B...
Landmark Proton Therapy Data Changes the Conversation; LIXTE Biotechnology (LIXT) Saw It Coming
A landmark Phase III trial shows proton therapy significantly improves survival for oropharyngeal cancer patients, validating LIXTE Biotechnology's st...
HeartBeam Partners With Mount Sinai to Advance AI-Powered ECG Technology
HeartBeam (BEAT) collaborates with Mount Sinai to develop and validate AI-based ECG algorithms, aiming to enhance personalized cardiac monitoring and ...
Okogen Acquires Ranpirnase Assets, Expanding Antiviral Pipeline Beyond Ophthalmology
Okogen Inc. has acquired the global intellectual property and development assets for ranpirnase from Orgenesis Inc., strengthening its ophthalmic prog...
American Heart Association Awards $32,000 in Grants to High Schools and Colleges for CPR Training and Safety Resources
The American Heart Association has awarded Nation of Lifesaver grants to 33 high schools and colleges in 20 states to fund CPR training, cardiac emerg...
NeuroOne Completes Limited Market Release of OneRF Trigeminal Nerve Ablation System, Reports 100% Pain Freedom in Initial 12 Patients
NeuroOne Medical Technologies announced that all 12 patients treated with its OneRF Trigeminal Nerve Ablation System during a limited market release r...
Lexaria Expands Patent Portfolio with Five New Grants, Including Two for GLP-1 Diabetes Treatments
Lexaria Bioscience Corp. received five new patents, including two for diabetes treatment using its DehydraTECH technology with GLP-1 drugs, strengthen...
Oragenics Reports Going Concern Audit Opinion, Raising Questions About Financial Stability
Oragenics Inc. disclosed a going concern audit opinion for fiscal 2025, highlighting potential financial risks as it advances its lead concussion trea...
Soligenix Receives EU Orphan Drug Designation for Dusquetide in Behçet Disease
Soligenix announced EU orphan drug designation for dusquetide in Behçet disease, providing up to 10 years of market exclusivity and advancing its inna...
NextPlat Partners With HealthWarehouse to Expand Nationwide Healthcare Fulfillment
NextPlat Corp. partners with HealthWarehouse.com to enable nationwide prescription and OTC fulfillment, expanding its U.S. healthcare footprint beyond...
Soligenix Reports 2025 Results, Highlights Phase 3 CTCL Progress and Orphan Drug Milestones
Soligenix announced progress in its Phase 3 FLASH2 trial for cutaneous T-cell lymphoma and orphan drug designation for dusquetide in Behçet’s Disease,...
Nutriband Selects Global Brand Name for AVERSA Fentanyl Patch, Targeting Abuse Deterrence
Nutriband announced the selection of a proposed worldwide brand name for its abuse-deterrent fentanyl patch, aiming to be the first such product to re...
Lantern Pharma Advances AI-Driven Oncology Pipeline With Multiple 2026 Milestones
Lantern Pharma reports continued progress in its AI-driven oncology pipeline, including the LP-300 Phase 2 HARMONIC trial and planned FDA discussions,...
Telomir Pharmaceuticals Submits IND for Telomir-1 Targeting Triple-Negative Breast Cancer
Telomir Pharmaceuticals has submitted an Investigational New Drug application to the FDA for Telomir-1, a novel oral therapy for advanced triple-negat...
NextPlat Corp Reports 2025 Results, Positions for Growth After Significant Cost Reductions
NextPlat Corp reported a 18% decline in 2025 revenue to $54.3 million, but achieved a 50% reduction in operating expenses and strengthened its balance...
Annovis Bio Highlights Buntanetap Development in The Scientist Publication
Annovis Bio's lead drug candidate buntanetap, featured in The Scientist, shows promise in Phase 3 trials for Alzheimer's and Parkinson's diseases.
Tonix Pharmaceuticals Reports Positive Phase 1 Data for Lyme Disease Prophylaxis Candidate TNX-4800
Tonix Pharmaceuticals announced Phase 1 results for TNX-4800, a long-acting monoclonal antibody for Lyme disease prevention, showing sustained protect...
The Midwife in Vienna Launches Baby’s First Bath on Amazon.com, Bringing European Newborn Care to U.S. Families
The Midwife in Vienna announces the U.S. availability of Baby’s First Bath on Amazon.com, offering a gentle, European-inspired newborn bathing experie...
Stigma Around Lice Prolonging Atlanta School Outbreaks
Atlanta lice experts report a 20-25% rise in school lice cases in 2026, with stigma and pesticide resistance fueling longer outbreaks, highlighting th...
Rawle Orthodontics Offers Clear Aligners for All Ages in Altamonte Springs, FL
Rawle Orthodontics in Altamonte Springs provides clear aligner treatment for children, teens, and adults, offering a discreet, comfortable, and effect...
Littleton Family Dentist Southbridge Dentistry Offers Full-Spectrum Dental Care Since 1982
Southbridge Dentistry, a Littleton family dentist established in 1982, provides comprehensive dental services from preventive care to advanced restora...
Preventive Dental Care Key to Long-Term Health, Says Bethesda Practice
Dentistry of Bethesda emphasizes the importance of routine preventive dental care for overall health, offering personalized services for all ages.
Sonora Dentist Offers Expert Care for Broken Tooth Emergencies and Dental Crises
Jeff Berger Dentistry provides prompt, professional care for dental emergencies, emphasizing that early intervention in cases like broken teeth can pr...
Boller Orthodontic Arts Opens Two Locations in Crown Point and Dyer, Expanding Access to Orthodontic Care in Northwest Indiana
Boller Orthodontic Arts has established two locations in Crown Point and Dyer, Indiana, to provide accessible, high-quality orthodontic care for famil...
Cohen Family Smiles Expands Pediatric Dentistry Services in Yorktown Heights, NY
Cohen Family Smiles offers comprehensive pediatric dentistry in Yorktown Heights, emphasizing preventive care, early intervention, and a child-friendl...
Dorfman Orthodontic Group Delivers Personalized Smile Transformations in Bensalem, PA
Dr. Jake Dorfman's practice offers braces and Invisalign with a patient-centered approach, combining advanced technology and community commitment to m...
Dorfman Orthodontic Group Brings Personalized Care and Advanced Orthodontic Solutions to Southampton, PA
Dr. Jake Dorfman's practice offers braces and Invisalign with a patient-centered approach, emphasizing clinical expertise and individualized treatment...
HeartBeam Inc. Achieves Key Regulatory Milestone, Analyst Upgrade Signals Commercial Transition
HeartBeam received FDA clearance for its 12-lead ECG synthesis software, leading to an analyst upgrade and highlighting a pivotal shift toward commerc...
GeoVax Announces Warrant Inducement Transaction to Raise Approximately $863,000
GeoVax Labs has entered into a warrant inducement agreement with institutional investors to raise gross proceeds of about $863,000 by reducing the exe...
Vycor Medical Reports 17% Revenue Growth in 2025, Driven by International Expansion of ViewSite Brain Access System
Vycor Medical announced a 17% increase in total revenue to $1.86 million for 2025, driven by 18% growth in its Vycor Medical division, highlighting su...
LIXTE Biotechnology Expands LB-100 Clinical Trials Targeting Ovarian and Colon Cancers
LIXTE Biotechnology announces expanded clinical trials for its lead compound LB-100, aiming to address treatment challenges in ovarian clear cell carc...
LIXTE Biotechnology’s LB-100: A Unique PP2A Inhibitor in Clinical Development
LIXTE Biotechnology Holdings holds the world’s only clinical-stage PP2A inhibitor, LB-100, which enhances cancer cell sensitivity to therapies and dis...
Soligenix Expands Rare Disease Pipeline with UK Designation for SGX945
Soligenix's investigational therapy SGX945 receives Promising Innovative Medicine designation in the UK, underscoring its potential and the company's ...
Cardio Diagnostics Holdings: Addressing Cardiovascular Disease with AI-Powered Precision Medicine
Cardio Diagnostics Holdings leverages AI and epigenetic biomarkers to provide personalized cardiovascular insights, aiming to reduce the leading cause...